FDCDDQ
ACAD icon

Federation des caisses Desjardins du Quebec’s Acadia Pharmaceuticals ACAD Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.8K Buy
190
+61
+47% +$1.34K ﹤0.01% 2602
2026
Q1 		$2.86K Buy
+129
New +$3.08K ﹤0.01% 2612
2021
Q3 		– Sell
-229
Closed -$5.58K – 2550
2021
Q2 		$5.58K Hold
229
– – ﹤0.01% 2201
2021
Q1 		$5.91K Buy
+229
New +$10.1K ﹤0.01% 2153

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ACAD Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Acadia Pharmaceuticals (ACAD) stake by 47% in Q2 2026, buying an estimated $1.34K and bringing the position to 190 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Federation des caisses Desjardins du Quebec first reported a position in ACAD in Q1 2021 and has held it in 4 quarters since. The position peaked at $5.91K in Q1 2021. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 190 shares of Acadia Pharmaceuticals worth $4.8K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 61 Acadia Pharmaceuticals shares in Q2 2026, an estimated $1.34K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2602 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Acadia Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Federation des caisses Desjardins du Quebec's Acadia Pharmaceuticals position peaked at $5.91K in Q1 2021.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.